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oxytocin modulates the temporal 
dynamics of resting eeG networks
Bastian Schiller1,2, Thomas Koenig3 & Markus Heinrichs1,2
Oxytocin is a key modulator of social interaction, but we possess little knowledge of its underlying 
effects on neuropsychological processes. We used a spatio-temporal EEG microstates analysis to reveal 
oxytocin’s effects on the temporal dynamics of intrinsically generated activity in neural networks. Given 
oxytocin’s known anxiolytic effects, we hypothesized that it increases the temporal stability of the 
four archetypal EEG resting networks. Eighty-six male participants had received oxytocin or placebo 
intranasally before we recorded their resting EEG. As hypothesized, oxytocin globally increased the 
average duration of the four archetypal resting networks and specifically decreased the occurrence 
and coverage of an autonomic processing-related network to benefit greater coverage of an attention-
related network. Moreover, these neurophysiological changes were more pronounced in participants 
with high anxiety levels and strong subjectively experienced effects of the oxytocin administration. 
In sum, our study shows that oxytocin reduces rapid switching among neural resting networks by 
increasing their temporal stability. Specifically, it seems to reduce the brain’s need for preparing 
the internally-oriented processing of autonomic information, thus enabling the externally-oriented 
processing of social information. Changes in the temporal dynamics of resting networks might underlie 
oxytocin’s anxiolytic effects - potentially informing innovative psychobiological treatment strategies.
In the past 15 years, a plethora of intranasal application studies has identified the hypothalamic neuropeptide 
oxytocin as a key modulator of social cognition and behavior in humans1–4. Yet we still possess little empirical evi-
dence of changes in specific neuropsychological processes underlying oxytocin’s effects, evidence sorely missed in 
tailoring, monitoring, and evaluating individual treatment applications of this neuropeptide in order to improve 
social malfunctioning1,5. To generate such evidence, we here study oxytocin’s effects on the temporal dynamics 
of neural networks at rest by applying a spatio-temporal analysis of multichannel electroencephalography6–8. 
The applied analysis approach adds to previous research that has mostly relied on metabolic neuroimaging2,9–11 
in three respects. First, it examines changes in scalp electrical potential topographies, which indicate changes in 
global network activity, thereby taking into account that even rather circumscribed neuropsychological processes 
involve massive parallel processing in distributed neural networks12. Second, it examines these networks’ intrin-
sically generated activity, which optimally prepares the individual for forthcoming stimuli processing13, thus 
enabling us to identify oxytocin’s general neuropsychological effects independent from specific social contexts14. 
Third, it examines the temporal dynamics of neural resting networks which mediate specific neuropsychological 
processes by undergoing rapid reorganization into different spatial patterns15, uniquely revealing oxytocin’s effects 
on switching among neural resting networks on a milliseconds scale.
Research applying metabolic neuroimaging to reveal oxytocin’s effects on neural processing at rest in the 
spatial domain has demonstrated modulatory effects on the connectivity between distinct neural regions 
(e.g., amygdala-prefrontal connectivity16–18; cortico-striatal connectivity19; striatal/pallidal-frontal and 
striatal-cerebellar connectivity20). Recent studies have also reported oxytocin-induced changes in large-scale 
neural resting networks, suggesting a modulation of neural communication between attention-, saliency-, and 
default mode-related networks11,21. However, as intrinsically generated brain activity at rest is thought to opti-
mally prepare the individual for forthcoming, often unpredictable and rapidly changing stimulus processing, the 
reorganizing of neural networks must occur on a sub-second time scale7. Therefore, it could be highly informative 
to supplement knowledge gained from metabolic neuroimaging research with knowledge on oxytocin’s effects on 
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neural processing at rest in the temporal domain by using neuroimaging methods with high temporal resolution, 
such as electroencephalography (EEG; for a recent example, see22).
More specifically, the applied spatio-temporal analysis approach clusters the resting EEG signal into a lim-
ited number of scalp electrical potential topographies that remain stable for certain time periods (60–120 ms) 
before dynamically changing into a different topography that remains stable again (for recent studies taking this 
approach, see23,24). These time periods of stable topographies are known as “microstates”, and transitions between 
microstates are believed to represent sequential coordinated activity of various, distributed neural networks6,7. 
Remarkably, just four archetypal topographies (termed microstate A-D25) explain large portions of the global 
variance in the EEG data (>70%). These four states have been proven to be highly reproducible across multiple 
independent studies and may result from evolutionarily determined, brain-intrinsic biases toward particular pat-
terns of co-activation particularly suited to representing environmentally relevant information7. The temporal 
dynamics of these four microstates (average duration = temporal stability, average occurrence = usage, cover-
age = presence, transitions = communication between networks) are known to vary across various behaviors, 
personality types, and neuropsychiatric disorders26. To interpret these variations, researchers have attempted to 
link these four microstates to specific underlying neural networks, with microstates A and B being associated with 
sensory processing (microstate A: audition; microstate B: vision), microstate C with autonomic processing, and 
microstate D with attention-related processing7,26. Analyzing how oxytocin modulates the temporal dynamics 
of these four archetypal resting networks thus holds the potential to deepen our understanding of its effects on 
specific neuropsychological processes.
Based on the vast literature on oxytocin research in humans, which hypotheses can one derive regarding 
its effects on specific neuropsychological processes? Pioneering evidence that oxytocin reduces subjective and 
neuroendocrine responses to psychosocial stress27 has inspired a plethora of studies repeatedly demonstrating 
oxytocin’s anxiolytic effects1,2. Metabolic neuroimaging studies have revealed that these effects are due to changes 
in the activity in and connectivity between neural regions shown to mediate negative affective experiences (e.g., 
the amygdala, insula2,9,10). Whereas these studies have identified neural target regions of oxytocin’s anxiolytic 
effects, the fluctuations observed using metabolic neuroimaging occur too slowly to be associated with neural 
networks’ intrinsically generated activity associated with preparing for a quick and adaptive reaction to poten-
tially threatening stimuli28,29. Therefore, the present study utilizes high temporal resolution 64-channel EEG in 
order to reveal oxytocin-induced modulations of the temporal dynamics of neural resting networks on the mil-
liseconds scale which might mediate oxytocin’s anxiolytic effects. For that purpose, we analyzed eighty-six male 
participants’ resting EEG, which we recorded 45 minutes after they had received oxytocin or placebo treatment 
intranasally27,30,31.
Given oxytocin’s known anxiolytic effects1,2, we hypothesized that it increases neural networks’ temporal sta-
bility and induces a shift from internally- to externally-oriented processing modes at rest. Because of the associ-
ation of microstate C with interoceptive-autonomic processing32,33 and the association of hyperactive autonomic 
processing at rest with anxiety34,35, we hypothesized that oxytocin decreases the usage and presence of autonomic 
processing-related microstate C in favor of attention-related microstate D. We did not expect changes with regard 
to the usage and presence of sensory-processing-related microstates A and B. On an exploratory level, we also 
analyzed oxytocin’s effects on the communication (i.e., transitions) between microstates. Furthermore, if these 
hypothetical changes in neural networks’ temporal dynamics do underlie oxytocin’s anxiolytic effects, we should 
also observe those changes being moderated by anxiety-related traits (e.g., neuroticism36, anxious attachment 
style37, dependent attachment style37). Participants with high anxiety levels should benefit more from oxytocin’s 
anxiolytic effects than those with low anxiety levels (for a review on individual moderators of oxytocin’s effects, 
see14). Finally, we analyzed whether the aforementioned changes in neural networks’ temporal dynamics after 
oxytocin administration are moderated by subjective ratings of experienced substance effects. Such an association 
would provide innovative evidence that neurophysiological changes could inform the designing of individualized, 
therapeutic applications of the neuropeptide.
Results
The four archetypal microstates. The applied cluster analysis identified the four archetypal microstate 
topographies A-D that were exhibited by participants in both the placebo and oxytocin group (Fig. 1). These maps 
did not differ with respect to their topography between treatment groups (microstate A: P > 0.20, microstate B: 
P = 0.157, microstate C: P > 0.20; microstate D: P = 0.083), which allows us to compare characteristics of the same 
underlying neural networks between participants in the placebo and oxytocin groups. On average, the four maps 
explained 78.32% of the variance in our data (s.d. = 3.53%; range: 68–85%).
Temporal dynamics of resting networks under oxytocin vs. placebo treatment. To compare the 
temporal dynamics of resting networks (duration, occurrence, coverage, transitions) between treatment groups 
(for descriptive statics see Supplementary Table S1), we calculated ANOVAs with the between-participants fac-
tor “treatment” (oxytocin vs. placebo) and the within-participants factor “microstate class” (four levels: micro-
state A-D) or “microstate class transition” (twelve levels: from microstate A-D [4] to microstate A-D [3]). As the 
present study focuses on oxytocin’s effects on neural resting networks, we will only report those effects including 
the “treatment” factor in the following (please see Supplementary Results for main effects of “microstate class” 
and post-hoc LSD tests).
Regarding the duration of microstates, we observed a significant effect of “treatment” (F(1,84) = 6.163, 
P = 0.015, ETA2 = 0.068), but no interaction effect of “treatment x microstate class” (F(3,252) = 1.280, 
P > 0.20). The mean duration of microstates was significantly longer under oxytocin treatment (M = 81.1 ms, 
s.d. = 11.45 ms) than placebo treatment (M = 75.2 ms, s.d. = 11.37 ms; Fig. 2a). Thus, as hypothesized, oxytocin 
increased the temporal stability of resting networks.
3Scientific RepoRtS |         (2019) 9:13418  | https://doi.org/10.1038/s41598-019-49636-6
www.nature.com/scientificreportswww.nature.com/scientificreports/
Figure 1. Microstate maps. Topographies of the four archetypal microstates A-D7,25, identified in the oxytocin 
group (first row), the placebo group (second row), and the whole sample (third row). Head seen from above, 
nose up, left ear left. Red and blue are the arbitrarily chosen color labels for areas of opposite polarity. Please 
note that the topographies of the four microstates did not differ between treatment groups (all Ps > 0.083).
Figure 2. Box-plots (lower end of the whisker: 2.5% percentile; lower horizontal end of the box = 25% 
percentile; middle horizontal line = median; upper horizontal end of the box = 75% percentile; upper end of the 
whisker: 97.5% percentile) depicting differences in the temporal dynamics of microstates, i.e., resting networks 
under oxytocin (grey color) and placebo (black color) treatment. Asterisks indicate significant differences 
between treatment groups (P < 0.10) (a) Differences in mean duration in milliseconds (ms). The mean duration 
of microstates was longer under oxytocin treatment (main effect “treatment”, P = 0.015). (b) Differences in 
mean occurrence in times per second. Microstate B (P = 0.003) and microstate C (P = 0.004) occurred less often 
under oxytocin treatment (interaction effect of “microstate class x treatment”, P = 0.009). (c) Differences in 
coverage in % of signal. Microstate C covered, on a marginally significant level, less time (P = 0.054), whereas 
microstate D covered more time under oxytocin treatment (P = 0.027; interaction effect of “microstate class 
x treatment”, P = 0.024). (d) Difference in transitions in Δ% (observed-expected; see Methods). There were 
fewer transitions from microstate B to C under oxytocin treatment (microstate B→C: P = 0.004, Bonferroni-
corrected; interaction effect of “microstate class transition x treatment”, P = 0.050).
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Regarding the occurrence of microstates, we noted a significant effect of “treatment” (F(1,84) = 5.919, 
P = 0.017, ETA2 = 0.066), and an interaction effect of “microstate class x treatment” (F(3,252) = 3.486, P = 0.016, 
ETA2 = 0.040). Microstate B (F(1,84) = 9.379, P = 0.003, ETA2 = 0.100) and microstate C (F(1,84) = 8.982, 
P = 0.004, ETA2 = 0.097) occurred less often under oxytocin treatment (microstate B: M = 2.99/s, s.d. = 0.56/s; 
microstate C: M = 3.21/s, s.d. = 0.58/s) than placebo treatment (microstate B: M = 3.40/s, s.d. = 0.66/s; MS_C: 
M = 3.62/s, s.d. = 0.69/s; Fig. 2b). Thus, as hypothesized, oxytocin reduced the occurrence of autonomic 
processing-related microstate C. Furthermore, it decreased the occurrence of visual processing-related micro-
state B.
Regarding the coverage of microstates, we found a significant effect of “treatment” (F(1,84) = 6.172, 
P = 0.015, ETA2 = 0.068) and an interaction effect of “microstate class x treatment” (F(3,252) = 2.752, P = 0.043, 
ETA2 = 0.032). Microstate C revealed, on a marginally significant level, less coverage (F(1,84) = 3.810, P = 0.054, 
ETA2 = 0.043) under oxytocin treatment (M = 25.47%, s.d. = 4.01%) compared to placebo treatment (M = 27.27%, 
s.d. = 4.56%). In contrast, microstate D exhibited more coverage (F(1,84) = 5.046, P = 0.027, ETA2 = 0.057) under 
oxytocin treatment (M = 24.90%, s.d. = 4.84%) than placebo treatment (M = 22.67%, s.d. = 4.35%; Fig. 2c). Thus, 
as hypothesized, oxytocin decreased the time covered by autonomic processing-related microstate C. Meanwhile, 
it increased the time covered by attention-related microstate D.
Regarding the transitions between microstates, we found a significant interaction effect of “microstate class 
transition x treatment” (F(4.75,398.60) = 2.277, P = 0.050, ETA2 = 0.026). We detected fewer bilateral transitions 
from microstate B to C under oxytocin-treatment (microstate B → C: placebo: M = 0.36%, s.d. = 0.79%; oxytocin: 
M = −0.13%, s.d. = 0.74%; F(1,84) = 8.683, P = 0.004, ETA2 = 0.094, Bonferroni-corrected Fig. 2d). In sum, oxytocin 
decreased transitions from visual processing-related microstate B to autonomic processing-related microstate C.
Moderation of treatment effects by anxiety-related traits. To corroborate our hypothesis that the 
observed differences in temporal dynamics of resting networks under oxytocin compared to placebo treatment 
underlie oxytocin’s anxiolytic effects, we examined whether these differences were more pronounced in partici-
pants with high anxiety levels (for details see Supplementary Tab. S2).
Regarding oxytocin’s effect on microstates’ mean duration, we identified a moderation by anxious attachment 
style (Δ R2 = 8.34%, F(1,82) = 7.193, P = 0.009), dependent attachment style (Δ R2 = 10.97%, F(1,82) = 8.551, 
P = 0.005), and by neuroticism (Δ R2 = 4.98%, F(1,82) = 4.117, P = 0.046). As hypothesized, oxytocin’s effects 
were more pronounced in people with dependent attachment styles (R(41) = 0.42, P = 0.005; Fig. 3b), and, on a 
marginally significant level, in people with anxious attachment styles (R(41) = 0.288, P = 0.061; Fig. 3a) and high 
levels of neuroticism (R(41) = 0.263, P = 0.089; Fig. 3c).
Regarding oxytocin’s effect on the occurrence of microstate C, we found a moderation by anxious attach-
ment style (Δ R2 = 10.45%, F(1,82) = 9.072, P = 0.004), and by dependent attachment style (Δ R2 = 10.51%, 
F(1,82) = 6.951, P = 0.010). As hypothesized, oxytocin’s effects were more pronounced in people with anx-
ious (R(41) = −0.334, P = 0.029; Supplementary Fig. S1a) and dependent attachment styles (R(41) = −0.397, 
P = 0.008; Supplementary Fig. S1b).
Regarding oxytocin’s effect on the coverage of microstate C, we noted a moderation by anxious attachment style 
(Δ R2 = 6.44%, F(1,82) = 4.846, P = 0.031). As hypothesized, oxytocin’s effect was more pronounced in people 
with an anxious attachment style (R(41) = −0.352, P = 0.021; Supplementary Fig. S1c). Regarding the coverage of 
microstate D, we found a moderation by dependent attachment style (Δ R2 = 6.05%, F(1,82) = 4.773, P = 0.032). 
Again, this effect was, on a marginally significant level, more pronounced in people with dependent attachment 
style (R(41) = 0.285, P = 0.064; Supplementary Fig. S1d).
Regarding oxytocin’s effect on the transitions from microstate B to microstate C, we observed a moderation 
by anxious attachment style (Δ R2 = 6.26%, F(1,82) = 8.585, P = 0.004). As hypothesized, this effect was more 
pronounced in people with an anxious attachment style (R(41) = −0.384, P = 0.011; Supplementary Fig. S1f).
In sum, we found that several anxiety-related traits moderated oxytocin’s effects, with more pronounced 
effects in participants possessing high anxiety levels. Together, these findings provide converging evidence that 
changes in neural resting networks’ temporal dynamics underlie oxytocin’s anxiolytic effects.
Moderation of treatment effects by subjectively experienced substance effects. Finally, we ana-
lyzed whether oxytocin-induced changes in neural networks’ temporal dynamics were moderated by subjectively 
experienced substance effects (for details see Supplementary Tab. S2). Please note that overall and in line with 
previous research38, there were no differences in subjectively experienced substance effects or in the estimated 
substance between treatment conditions (both P > 0.20).
With regard to microstates’ mean duration, we observed a moderation by subjectively experienced sub-
stance effects (Δ R2 = 5.26%, F(1,82) = 4.167, P = 0.044). As hypothesized, participants revealing stronger 
oxytocin-induced increases in the temporal stability of resting networks subjectively experienced stronger sub-
stance effects (R(41) = 0.383, P = 0.011; Fig. 3d).
Discussion
By utilizing a spatio-temporal analysis of 64-channel EEG recorded at rest, the present study provides innova-
tive evidence of oxytocin-induced changes in the temporal dynamics of neural resting networks. In line with 
oxytocin’s assumed anxiolytic effects, oxytocin administration (1) increased the temporal stability of neural rest-
ing networks, (2) decreased the usage and presence of autonomic processing-related microstate C in favor of 
attention-related microstate D, and (3) decreased communication between the visual-processing related network 
microstate B and autonomic processing-related microstate C. Anxiety-related traits moderated these changes, 
with stronger changes in those participants with high rather than low anxiety levels, providing further evidence 
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of oxytocin’s anxiolytic effects. Finally, we observed that the above-mentioned changes correlate with subjectively 
experienced effects from the oxytocin administration. In sum, the observed oxytocin-induced changes in neu-
ral resting networks’ temporal dynamics reveal mechanistic insights into oxytocin’s effects on neuropsycholog-
ical processes and could potentially inform innovative psychobiological treatment strategies for anxiety-related 
disorders39,40.
Our findings contribute to the scarce knowledge about oxytocin’s effects on neural processing in the tem-
poral domain. Interestingly, we have long known that oxytocin administration affects the processing of very 
briefly presented stimuli (e.g., 18 milliseconds41). As already indicated by this finding, one must rely on neu-
roscientific methods with high temporal resolution to thoroughly comprehend oxytocin’s neural effects. In 
doing so, we here show that oxytocin modulates the temporal dynamics of neural resting networks on a mil-
liseconds scale. Our approach differs from previous EEG research reporting complex and context-dependent 
oxytocin-induced modulations of both event-related potentials42,43 and electrophysiological oscillations44,45 dur-
ing the processing of social stimuli. By investigating oxytocin’s effects on the temporal dynamics of neural net-
works’ intrinsically generated activity while the brain is preparing for forthcoming stimuli processing, this study 
reveals oxytocin’s general and context-independent effects on neuropsychological processes. To our knowledge, 
only one other study has investigated oxytocin’s effects on resting EEG. Using a frequency analysis, that study 
showed that oxytocin decreases cross-frequency coupling across slow and fast oscillations occurring on a seconds 
scale22. In contrast, the spatio-temporal analysis approach we took in this study reveals how oxytocin modu-
lates amplitude-independent and broad-band temporal dynamics of neural resting networks (i.e., their duration, 
occurrence, coverage, and transitions) occurring on a milliseconds scale7,25.
We identified several changes in these neural resting networks’ temporal dynamics. Globally, we found that 
all networks were present for longer duration under oxytocin vs. placebo treatment, indicating that oxytocin 
increased the temporal stability of resting networks. This effect might represent an adaptive stabilization of neural 
processing at rest, as decreased temporal stability of resting networks has been associated with several pathologi-
cal states such as dementia46,47, depression48, and schizophrenia46. Furthermore, we found that oxytocin decreased 
the usage and presence of microstate C to benefit increased coverage of microstate D. Previous research has sug-
gested antagonistic functional roles of microstate C and D33,49, with microstate C associated with a fronto-insular 
network involved in interoceptive-autonomic processing32,33, and microstate D associated with a fronto-parietal 
network involved in (re)orienting attention to external stimuli32,50. The oxytocin-induced change observed in the 
balance between microstate C and D toward a relatively increased presence of microstate D might thus indicate 
Figure 3. Significant moderations (all Ps < 0.046) of oxytocin-induced increases in the temporal stability of 
resting networks by anxiety-related traits (anxious and dependent attachment styles of the AAS37,58 and scale 
“neuroticism” of the NEO-FFI36). Depicted are the correlations (including 95% confidence intervals) between 
mean microstate duration (ms; x-axis) and anxiety-related traits (a: anxious attachment style; b: dependent 
attachment style; c: neuroticism) and subjectively experienced substance effects (d) separately for participants 
of the placebo (in black) and oxytocin condition (in grey). Oxytocin-induced increases in the temporal stability 
of resting networks were more pronounced in participants with higher levels of anxiety-related traits (i.e., more 
anxious and dependent attachment styles, higher levels of neuroticism) and stronger subjectively experienced 
substance effects.
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a dampening of anxiety-related autonomous processing and a shift from internally- to externally-oriented pro-
cessing modes at rest51. In line with this interpretation, oxytocin decreased the usage of visual processing-related 
microstate B and its communication to autonomic-processing related microstate C. These findings are also of 
interest given that oxytocin is being discussed as a potential add-on in the treatment of schizophrenia52,53, in 
which microstate C is more present and microstate D is less present49. Together, our findings provide converging 
evidence of a potential neurobiological mechanism underlying oxytocin’s evolutionarily-conserved role as an 
anxiolytic facilitator of social interactions1–3: while being in an unknown environment at rest, it might increase 
the temporal stability of neural networks and prepare the brain for the processing of external social instead of 
internal autonomic information.
Further evidence for these assumed anxiolytic effects comes from the finding that the oxytocin-induced 
changes we observed in neural networks’ temporal dynamics were more pronounced in participants with high 
levels of several anxiety-related traits. We found that participants with an anxious attachment style displayed 
larger increases in networks’ temporal stability, larger decreases in the usage and coverage of the autonomic 
processing-related microstate C, and larger decreases in the communication from vision-related microstate B to 
microstate C; participants with a dependent attachment style displayed larger increases in networks’ temporal 
stability, larger decreases in the usage of microstate C, and larger increases in the coverage of attention-related 
microstate D. These findings are in line with previous research showing that, in general, individual traits moderate 
oxytocin’s effects14, and, in specific, oxytocin’s effects are stronger in participants with anxious attachment styles54. 
With regard to the potential clinical applications of oxytocin, they suggest that participants with high anxiety 
levels could benefit more from oxytocin’s anxiolytic effects than those with low anxiety levels. Given that we have 
detected a positive correlation between increases in networks’ stability and subjectively experienced effects in the 
oxytocin group, participants with particularly strong neurophysiological changes might even be able to report 
such beneficial effects.
In sum, our study demonstrates that spatio-temporal analysis of resting EEG provides highly valuable 
knowledge on oxytocin’s effects on neural networks’ dynamics on a milliseconds scale55. Future studies might 
experimentally modify the environment of resting EEG recordings56. For example, one could introduce obser-
vation by an experimenter57 to investigate whether oxytocin-induced anxiolytic neurophysiological effects are 
stronger in a social evaluation context. It could also prove worthwhile to extend this research to populations with 
anxiety-related disorders, in order to study whether oxytocin administration normalizes dysfunctional patterns of 
resting networks’ temporal dynamics. Future studies might more closely investigate the nature of the correlation 
between oxytocin-induced changes in neural networks’ temporal dynamics, and subjectively experienced effects, 
for example by utilizing more specific questions about subjectively experienced anxiolytic effects (e.g., feeling 
calmer, less tense). If future evidence solidifies that changes in neural networks’ temporal dynamics underlie 
oxytocin’s anxiolytic effects, they could inform clinical applications of oxytocin to treat anxiety-related disorders.
Methods
Participants. All participants were free of a current or previous history of neurological or psychiatric disor-
ders, alcohol or drug abuse, or allergies to the preservatives used in nasal sprays. Ninety-one healthy male partici-
pants took part in this experiment. Five participants had to be excluded from further analysis because of excessive 
artifacts in their EEG recordings (<50% of data were available after automatic and manual artifact corrections), 
leaving a sample of 86 participants for analysis. Mean age was 23.7 y (s.d. = 4.59 y, range: 18–39 y). The Ethics 
Committee of the University of Freiburg approved this study, which was conducted according to the principles 
expressed in the Declaration of Helsinki. All procedures were carried out with the adequate understanding and 
informed consent of the participants.
Procedure. There were two appointments: during the first appointment, participants completed 
anxiety-related questionnaires (scale “neuroticism” of the NEO-FFI36; anxious and dependent attachment styles 
of the AAS37,58). The second appointment took place in the EEG laboratory. In a randomized, placebo-controlled, 
double-blind between-group design, participants received either 24 international units (IU) of oxytocin (N = 43) 
or placebo (N = 43) via intranasal administration59–61, following a well-established protocol27,31. Participants 
were then guided to an electrically shielded cabin in which 64-channel EEG measurements were prepared. The 
resting EEG protocol consisted of 20-s eyes open followed by 40-s eyes closed, repeated five times. This resting 
state paradigm has been routinely used in resting EEG research to minimize fluctuations in participants’ vigi-
lance state62–64, because participants can become drowsy already after 3 minutes of recording resting state brain 
activity if there is no alternation of eyes-open/eyes-closed periods65. The instructions about eye opening/closing 
were given via intercom. To exclude the possibility that instruction delivery confounds the resting state during 
the eyes-closed periods, we delivered instructions at the beginning and end of the eyes-open periods. Forty-five 
minutes after intranasal administration27,30,31, we measured each participant’s electroencephalogram during the 
resting state. We also collected subjective ratings on their experience of substance effects (7-point Likert Scale 
ranging from “1 = no effect at all” to “7 = very strong effect”). After these ratings, participants performed a social 
decision-making paradigm which will be analyzed elsewhere.
EEG recording. The EEG was recorded with a 64-channel recording system (Brainamp with actiCAP, Brain 
Products Gmbh, Munich) according to the 10–10 system montage66. Scalp impedance was kept below 10 kΩ. 
FCz served as the reference electrode, AFz as the ground electrode. Horizontal and vertical electrooculographic 
signals were recorded with two additional electrodes at the left and right outer canthi and one electrode at the 
left infraorbital. The EEG was online band-pass filtered between 0.1 and 100 Hz, and the data digitized with a 
sampling rate of 500 Hz.
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EEG Preprocessing. EEG data were preprocessed using Brain Vision Analyzer (Version 2.0.1.327; Brain 
Products GmbH, Munich). Only the 200 s eyes-closed periods were used for the analysis, because the influence 
of external visual stimulus processing and confounding eye blinks is minimized67,68. Data were band-pass filtered 
(high-pass 2 Hz, low-pass 20 Hz25) and re-derived to average reference. Ocular correction was conducted via a 
semi-automatic Independent Component Analysis (ICA)-based correction process. EEG signals with excessive 
noise were replaced by using a linear interpolation of adjacent electrodes. After an automatic artifact rejection 
(maximum amplitude: ±100 μV), data were visually examined by two independent raters to eliminate residual 
artifacts. Finally, artifact-free data were segmented into 2-s epochs for further analyses (M = 171 s, s.d. = 18 s, 
range: 86–192 s).
EEG microstate analysis. First, following the standard procedure6,69,70, the maps at the momentary peaks of 
the Global Field Power (i.e., maximum voltage values at all electrodes at that time point that represent time points 
of optimal signal-to-noise ratio) were extracted and submitted to a modified spatial cluster analysis using the 
atomize-agglomerate hierarchical clustering (AAHC71,72) method. In line with previous research72 we identified 
the four most dominant cluster maps in every single subject that represent the four archetypal EEG resting net-
works. In the second step, the cluster maps identified in each subject were submitted for a second cluster analysis 
to identify the dominant maps across all participants in each treatment group, yielding separate grand mean maps 
for participants under placebo and oxytocin treatment. Third, this analysis was repeated for the whole sample, 
yielding grand mean maps for the whole sample which were then sorted according to the standard labeling25 
(microstate A exhibits a left-right orientation, microstate B exhibits a right-left orientation, microstate C exhibits 
an anterior-posterior orientation, and microstate D exhibits a fronto-central maximum). Fourth, the grand mean 
maps of the placebo and oxytocin conditions were sorted according to the grand mean maps of the entire sample. 
Fifth, the maps of each individual were sorted according to the grand mean maps of the specific treatment group 
on the basis of spatial correlations. Sixth, and finally, the GFP peaks of individual EEG data were assigned to the 
individually identified cluster maps to which they fitted best. This assignment was linearly interpolated to the time 
periods between the GFP peaks, yielding a continuous temporal stream of microstates occurring in each indi-
vidual. We extracted four main microstates characteristics of interests from this last step: (1) The average micro-
state duration, representing an index of the temporal stability of the underlying resting network, (2) the average 
frequency of occurrence for each microstate independent of its individual duration, representing an index of the 
relative usage of the underlying resting network, (3) the total percentage of time during which a given microstate 
is dominant, representing the total presence of the underlying neural network, and (4) the number of observed 
transitions normalized for the overall count of transitions (“more transitions than expected from the number of 
occurrence of each microstate”) from one microstate to any other microstate which reveal sequential activation 
of and communication between the underlying neural networks.
Statistical analysis. To guarantee that the same EEG resting networks were present in both the oxytocin 
and placebo group, we first compared the topography of the mean maps of the two treatment groups using a 
randomization test (TANOVA), as implemented in Ragu software73–75. Next, we compared microstate charac-
teristics (duration, occurrence, coverage, transitions) between treatment groups calculating ANOVAs with the 
between-subjects factor “treatment” (oxytocin vs. placebo) and within-subjects factor “microstate class” (micro-
states A-D) or “microstate class transition” (twelve transitions, e.g., microstate A→B, microstate A→C, micro-
state A→D). We used parametric ANOVAs and report two-sided p-values. If the variances of the differences 
between treatment levels were unequal (Mauchly’s test for sphericity:  P > 0.05) we report Greenhouse-Geisser 
corrected P-values. In the main manuscript, we report only significant effects involving the factor “treatment” 
(for significant effects involving the factor “microstate class”, please see Supplementary Results). In case of sig-
nificant main or interaction effects, we calculated one-way ANOVAs comparing microstates characteristics 
between treatment groups; as we had no specific a priori hypotheses for microstates transitions, we applied 
Bonferroni-correction to these findings. For all significant effects, we also tested for significant moderation effects 
by anxiety-related personality traits and subjectively experienced substance effects using PROCESS76.
Data Availability
All data generated during and/or analyzed during the current study are available from the corresponding authors 
on reasonable request.
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